Top Story

Lung transplant increased risk for dysglycemia, new-onset diabetes

November 21, 2014

In the first year after undergoing a lung transplant, most patients experience dysglycemia and may also be at significant risk for new-onset diabetes, according to recent findings.

In the prospective, longitudinal study, researchers evaluated 156 patients aged ≥16 years who underwent single, bilateral or heart-lung transplants at the Alfred Hospital in Australia between August 2010 and December 2012. Those patients not being treated for diabetes mellitus underwent screening with a standard 75-g oral glucose tolerance test (OGTT) with insulin levels. The researchers also measured HbA1c in all patients before lung transplant at 3, 12, and 24 months after transplant. The 2006 WHO criteria were used to diagnose diabetes, impaired glucose tolerance and impaired fasting glycemia.

Meeting News Coverage

BMI cited as poor predictor of early complications after TJA

November 21, 2014
DALLAS — Results of a database review study presented here indicated a correlation between increased body mass index and 30-day complications for total joint…
In the Journals

Mobile telehealth program helped shift behavior in patients with diabetes

November 21, 2014
Behaviorally driven telephone health interventions can be used to address several pathways associated with sustained lifestyle change in patients with diabetes…
Lauren Sparks In the JournalsPerspective

Exercise response, epigenetic profiles key in improving type 2 diabetes interventions

November 21, 2014
Investigating exercise resistance mechanisms would lead to better understanding of how training efforts relate to type 2 diabetes and potentially allow targeted and new…
In the Journals

Clinical practice guideline published for Paget's disease diagnosis, treatment

November 20, 2014
A clinical practice guideline for the diagnosis and treatment of Paget’s disease of the bone has recently been released by the Endocrine Society and has been…
More News Headlines »
CME
Acromegaly: Challenges in Diagnosis - Part 2 of 5

Acromegaly: Pathophysiology, Signs, Symptoms, and Complications - Part 1 of 5

This activity is supported by an educational grant from Genentech.

An understanding of the pathophysiological mechanisms of acromegaly is important to its various complications as well…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Treatment of Acromegaly: Current Options - Part 3 of 5

Treatment of Acromegaly: Current Options - Part 3 of 5

This activity is supported by an educational grant from Genentech.

The goals of treatment for patients with acromegaly include controlling growth hormone excess, and relieving signs and…
More »
morganatic-roan
morganatic-roan